{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:24:08Z","timestamp":1755224648813,"version":"3.43.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Psychosom Med"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Sustained virological response (SVR) is the best indicator of successful therapy for hepatitis C virus (HCV) infection. Patients with chronic HCV infection treated with pegylated interferon-\u03b1 and ribavirin (PEG-IFN-\u03b1\/RBV) can achieve SVR 56% of the time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>This study aimed to evaluate baseline predictors of SVR in patients treated with PEG-IFN-\u03b1\/RBV for HCV chronic infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 101 patients receiving PEG-IFN-\u03b1\/RBV for chronic HCV infection participated in the prospective cohort study. Symptoms of depression were assessed with the Montgomery-\u00c5sberg Depression Rating Scale (MADRS) before the treatment. The multivariate regression analysis was applied to determine predictors of SVR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of a total of 101 patients included, 99 patients reached the primary end point\u201424 weeks after completing treatment. After the initial analysis of probable predictive variables, the logistic analysis included age, sex, HCV genetic type, and MADRS score. The HCV genotype (odds ratio = 0.22 [confidence interval = 0.073\u20130.68, <jats:italic toggle=\"yes\">p<\/jats:italic> = .008) and MADRS score (OR = 0.88 [confidence interval = 0.80\u20130.98), <jats:italic toggle=\"yes\">p<\/jats:italic> = .013]) predicted an SVR outcome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The severity of depressive symptoms before treatment and HCV genotype are independent predictors of SVR.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/psy.0000000000001274","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T10:00:56Z","timestamp":1704794456000},"page":"124-128","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The Severity of Depressive Symptoms as an Independent Predictor of Sustained Virological Response During Treatment of Hepatitis C With Pegylated Interferon-\u03b12a and Oral Ribavirin"],"prefix":"10.1097","volume":"86","author":[{"given":"Tomasz","family":"Paw\u0142owski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Radkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karol","family":"Perlejewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Laskus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Ma\u0142yszczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"bib1-20250812","doi-asserted-by":"crossref","first-page":"745076","DOI":"10.3389\/fmicb.2021.745076","article-title":"Contamination issue in viral metagenomics: problems, solutions, and clinical perspectives","volume":"12","year":"2021","journal-title":"Front Microbiol"},{"key":"bib2-20250812","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","year":"2002","journal-title":"N Engl J Med"},{"key":"bib3-20250812","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"bib4-20250812","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","article-title":"The new \u201c5-HT\u201d hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression","volume":"35","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"bib5-20250812","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.1503\/jpn.190139","article-title":"The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-\u03b12a and oral ribavirin","volume":"46","year":"2021","journal-title":"J Psychiatry Neurosci"},{"key":"bib6-20250812","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/apt.13633","article-title":"Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis","volume":"43","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"bib7-20250812","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/jvh.13069","article-title":"Interferon-free therapy as the cause of white matter tracts and cerebral perfusion recovery in patients with chronic hepatitis C","volume":"26","year":"2019","journal-title":"J Viral Hepat"},{"key":"bib8-20250812","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jns.2019.02.002","article-title":"Evaluation of brain volume alterations in HCV-infected patients after interferon-free therapy: a pilot study","volume":"399","year":"2019","journal-title":"J Neurol Sci"},{"key":"bib9-20250812","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12888-018-1735-6","article-title":"Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study","volume":"18","year":"2018","journal-title":"BMC Psychiatry"},{"key":"bib10-20250812","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/sj.mp.4001634","article-title":"Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response","volume":"10","year":"2005","journal-title":"Mol Psychiatry"},{"key":"bib11-20250812","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/hep.21791","article-title":"Hepatitis C treatment in \u201cdifficult-to-treat\u201d psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects","volume":"46","year":"2007","journal-title":"Hepatology"},{"key":"bib12-20250812","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.23699","article-title":"Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"bib13-20250812","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12876-017-0679-5","article-title":"Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin","volume":"17","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"bib14-20250812","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mpr.229","article-title":"Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C\u2014a critical review","volume":"16","year":"2007","journal-title":"Int J Methods Psychiatr Res"},{"key":"bib15-20250812","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archpsyc.1990.01810180089012","article-title":"SCAN. Schedules for Clinical Assessment in Neuropsychiatry","volume":"47","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"bib16-20250812","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","year":"1979","journal-title":"Br J Psychiatry"},{"key":"bib17-20250812","first-page":"165","article-title":"Assessment of depression scales reliability in the Polish population: the Bech-Rafaelsen Melancholia Scale, the Hamilton Depression Scale, and the Montgomery-Asberg Scale","volume":"8","year":"1999","journal-title":"Post Psychiatr Neurol"},{"key":"bib18-20250812","doi-asserted-by":"crossref","first-page":"15351","DOI":"10.3390\/ijms242015351","article-title":"Depression and cognitive dysfunction in patients with chronic hepatitis C: correlation with viral replication in the peripheral blood mononuclear cells and cytokines in serum","volume":"24","year":"2023","journal-title":"Int J Mol Sci"},{"key":"bib19-20250812","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.17219\/acem\/104617","article-title":"Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C","volume":"28","year":"2019","journal-title":"Adv Clin Exp Med"},{"issue":"Suppl 1","key":"bib20-20250812","first-page":"169","article-title":"Functional polymorphism in the interleukin 6 (IL6) gene with respect to depression induced in the course of interferon-\u03b1 and ribavirin treatment in chronic hepatitis patients","volume":"64","year":"2016","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"bib21-20250812","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/cells12060970","article-title":"HTR1A, TPH2, and 5-HTTLPR polymorphisms and their impact on the severity of depressive symptoms and on the concentration of tryptophan catabolites during hepatitis C treatment with pegylated interferon-\u03b12a and oral ribavirin (PEG-IFN-\u03b12a\/RBV)","volume":"12","year":"2023","journal-title":"Cell"},{"key":"bib22-20250812","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jmv.1890470112","article-title":"Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients","volume":"47","year":"1995","journal-title":"J Med Virol"},{"key":"bib23-20250812","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5604\/17322693.1038785","article-title":"Replication of hepatitis C virus in peripheral blood mononuclear cells in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin","volume":"67","year":"2013","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"bib24-20250812","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","article-title":"The bidirectional relationship of depression and inflammation: double trouble","volume":"107","year":"2020","journal-title":"Neuron"},{"key":"bib25-20250812","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jcv.2014.03.004","article-title":"Depression and neuroticism in patients with chronic hepatitis C: correlation with peripheral blood mononuclear cells activation","volume":"60","year":"2014","journal-title":"J Clin Virol"},{"key":"bib26-20250812","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12879-015-1305-1","article-title":"The correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis C outcome","volume":"15","year":"2015","journal-title":"BMC Infect Dis"},{"key":"bib27-20250812","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1128\/JVI.02248-06","article-title":"Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection","volume":"81","year":"2007","journal-title":"J Virol"},{"key":"bib28-20250812","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.06.004","article-title":"Alterations in the metabolism of tryptophan in patients with chronic hepatitis C six months after pegylated interferon-\u03b1 2a treatment","volume":"97","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"bib29-20250812","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","year":"2005","journal-title":"Immunity"},{"key":"bib30-20250812","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","year":"2010","journal-title":"J Immunol"},{"key":"bib31-20250812","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1365-2567.2002.01526.x","article-title":"Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division","volume":"107","year":"2002","journal-title":"Immunology"},{"key":"bib32-20250812","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1017\/S003329172000505X","article-title":"Associations between depression and cardiometabolic health: a 27-year longitudinal study","volume":"52","year":"2022","journal-title":"Psychol Med"},{"key":"bib33-20250812","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/jamapsychiatry.2020.1351","article-title":"Association of symptoms of depression with cardiovascular disease and mortality in low-, middle-, and high-income countries","volume":"77","year":"2020","journal-title":"JAMA Psychiatry"}],"container-title":["Psychosomatic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PSY.0000000000001274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T23:02:02Z","timestamp":1755039722000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PSY.0000000000001274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/psy.0000000000001274","relation":{},"ISSN":["1534-7796","0033-3174"],"issn-type":[{"type":"electronic","value":"1534-7796"},{"type":"print","value":"0033-3174"}],"subject":[],"published":{"date-parts":[[2024,1,8]]}}}